• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术(TIPS)治疗肝硬化合并不完全性主门静脉血栓形成的技术。

Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis.

机构信息

Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

出版信息

Sci Rep. 2016 Sep 13;6:33069. doi: 10.1038/srep33069.

DOI:10.1038/srep33069
PMID:27620282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5020493/
Abstract

The patients of liver cirrhosis associated with portal vein thrombosis (PVT) can be effectively treated by transjugular intrahepatic portosystemic stent shunt (TIPS). Although the corresponding TIPS procedures have already performed on the patients to different types of PVT, the procedures are not specific and the relationship between different types of PVT and technical success rate of TIPS is unclear. What's more, we aimed to explore the relationship between survival and vascular patency immediately after TIPS. 191 subjects underwent retrospective assessment. Appropriate TIPS procedures were performed based on our more specific classification. The overall success rate of TIPS was 95.8% (183/191). Success rate was significantly different between Grade II and Grade IV thrombosis (χ(2) = 5.294, P = 0.021). The 1-, 2-, 3-, 4-and 5-year survival rates were 95.6%, 89.1%, 83.1%, 76.5% and 67.8%, respectively. The overall survival time of completely patent PV and incomplete patent PV immediately after TIPS was 57.05 ± 0.75 vs. 39.12 ± 2.64 months, respectively (P < 0.0001). We conclude that appropriate TIPS procedures and lower grade of PVT are essential for better technical success rate of TIPS. The patency of target vessels is important for survival.

摘要

肝硬化伴门静脉血栓形成(PVT)的患者可以通过经颈静脉肝内门体分流术(TIPS)进行有效治疗。虽然已经对不同类型的 PVT 患者进行了相应的 TIPS 手术,但这些手术并不具体,不同类型的 PVT 与 TIPS 技术成功率之间的关系尚不清楚。此外,我们旨在探讨 TIPS 后即刻生存与血管通畅性之间的关系。对 191 例患者进行回顾性评估。根据我们更具体的分类,对患者进行适当的 TIPS 手术。TIPS 的总体成功率为 95.8%(183/191)。血栓形成程度为 II 级和 IV 级时,成功率有显著差异(χ(2) = 5.294,P = 0.021)。1、2、3、4 和 5 年的生存率分别为 95.6%、89.1%、83.1%、76.5%和 67.8%。TIPS 后即刻完全通畅和不完全通畅 PV 的总生存时间分别为 57.05±0.75 个月和 39.12±2.64 个月(P < 0.0001)。我们得出结论,适当的 TIPS 手术和较低等级的 PVT 是提高 TIPS 技术成功率的关键。靶血管通畅性对生存至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/9f74890cd1d6/srep33069-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/aee13d65ccc7/srep33069-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/7a8a267510f3/srep33069-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/4dcefa7bdc8c/srep33069-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/9f74890cd1d6/srep33069-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/aee13d65ccc7/srep33069-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/7a8a267510f3/srep33069-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/4dcefa7bdc8c/srep33069-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a62/5020493/9f74890cd1d6/srep33069-f4.jpg

相似文献

1
Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis.经颈静脉肝内门体分流术(TIPS)治疗肝硬化合并不完全性主门静脉血栓形成的技术。
Sci Rep. 2016 Sep 13;6:33069. doi: 10.1038/srep33069.
2
[Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis].门静脉血栓形成患者的经颈静脉肝内门体分流术
Rofo. 2008 Oct;180(10):899-905. doi: 10.1055/s-2008-1027698.
3
Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.慢性门静脉血栓形成的移植前门静脉再通和经颈静脉肝内门体分流术创建:61例患者队列的最终分析
J Vasc Interv Radiol. 2017 Dec;28(12):1714-1721.e2. doi: 10.1016/j.jvir.2017.08.005. Epub 2017 Oct 17.
4
Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.经颈静脉肝内门体分流术预防等待肝移植的肝硬化患者发生门静脉完全血栓形成的疗效
Transplant Proc. 2012 Nov;44(9):2603-5. doi: 10.1016/j.transproceed.2012.09.050.
5
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成伴静脉曲张出血:一项前瞻性队列研究的结果及预测因素
Liver Int. 2016 May;36(5):667-76. doi: 10.1111/liv.12929. Epub 2015 Aug 28.
6
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.经颈静脉肝内门体分流术对肝硬化患者门静脉血栓形成的短期和长期影响。
Gut. 2011 Jun;60(6):846-52. doi: 10.1136/gut.2010.228023. Epub 2011 Feb 28.
7
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化合并门静脉血栓形成并出现症状性门静脉高压。
J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.
8
Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.对于门静脉血栓形成的患者,经颈静脉肝内门体分流术治疗肝硬化门静脉高压的耐受性良好。
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):668-675. doi: 10.1097/MEG.0000000000001097.
9
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.经颈静脉肝内门体分流术(TIPS)治疗布加综合征或门静脉血栓形成:适应证及问题综述
Am J Gastroenterol. 1999 Mar;94(3):603-8. doi: 10.1111/j.1572-0241.1999.00921.x.
10
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.完全闭塞性门静脉血栓形成患者移植前门静脉再通——经颈静脉肝内门体分流术
Transplantation. 2015 Nov;99(11):2347-55. doi: 10.1097/TP.0000000000000729.

引用本文的文献

1
Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis.下腔静脉-脾静脉分流术治疗肝硬化门静脉主干完全闭塞及门静脉海绵样变性
Eur Radiol. 2025 Jun;35(6):3249-3255. doi: 10.1007/s00330-025-11571-8. Epub 2025 Apr 17.
2
Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai).肝硬化门静脉血栓形成管理共识(2020 上海)。
J Dig Dis. 2021 Apr;22(4):176-186. doi: 10.1111/1751-2980.12970. Epub 2021 Mar 7.
3
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

本文引用的文献

1
Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.经颈静脉肝内门体分流术治疗门静脉血栓形成:文献综述
Hepatol Int. 2012 Jun;6(3):576-90. doi: 10.1007/s12072-011-9324-5. Epub 2011 Dec 1.
2
Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.抗凝治疗可预防贲门胃底血管离断术后脾切除术后门脾静脉血栓形成。
World J Gastroenterol. 2012 Jul 14;18(26):3443-50. doi: 10.3748/wjg.v18.i26.3443.
3
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
4
Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.肝硬化门静脉血栓形成:诊断、自然病程及治疗挑战
Ann Gastroenterol. 2018 May-Jun;31(3):315-329. doi: 10.20524/aog.2018.0245. Epub 2018 Mar 3.
5
Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.肝硬化患者门静脉血栓形成的治疗时机:一位德国肝病学家的观点
J Transl Int Med. 2018 Mar 28;6(1):11-15. doi: 10.2478/jtim-2018-0003. eCollection 2018 Mar.
前瞻性评估抗凝和经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成。
Liver Int. 2012 Jul;32(6):919-27. doi: 10.1111/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.
4
TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period.食管胃静脉曲张出血治疗要点:单中心 12 年 128 例患者的临床转归。
J Vasc Interv Radiol. 2012 Feb;23(2):227-35. doi: 10.1016/j.jvir.2011.10.015. Epub 2011 Dec 16.
5
Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.经颈静脉肝内门体分流术对肝硬化患者门静脉血栓形成的短期和长期影响。
Gut. 2011 Jun;60(6):846-52. doi: 10.1136/gut.2010.228023. Epub 2011 Feb 28.
6
Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna.门静脉血栓形成与肝移植:博洛尼亚大学 10 年经验的演变。
Ann Surg. 2011 Feb;253(2):378-84. doi: 10.1097/SLA.0b013e318206818b.
7
Stage of portal vein thrombosis.门静脉血栓形成阶段。
J Hepatol. 2011 May;54(5):1080-2; author reply 1082-3. doi: 10.1016/j.jhep.2010.10.034. Epub 2010 Dec 5.
8
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.经颈静脉肝内门体分流术治疗肝硬化合并门静脉血栓形成并出现症状性门静脉高压。
J Hepatol. 2011 Jan;54(1):78-88. doi: 10.1016/j.jhep.2010.06.029. Epub 2010 Aug 27.
9
Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.低分子肝素抗凝治疗肝硬化患者门静脉血栓形成的安全性和有效性。
J Clin Gastroenterol. 2010 Jul;44(6):448-51. doi: 10.1097/MCG.0b013e3181b3ab44.
10
Vascular disorders of the liver.肝脏血管疾病
Hepatology. 2009 May;49(5):1729-64. doi: 10.1002/hep.22772.